Shortcomings In Patient Care For Elderly Breast Cancer Patients
9/23/2011

A study led by Professor Christos Markopoulos from Athens University Medical School in Athens, Greece presented at the 2011 European Multidisciplinary Cancer Congress, shows that women diagnosed with breast cancer late in life have a higher risk of mortality from the disease compared with younger patients, assuming they survive other age-related conditions...

Lung Cancer Research Team Awarded $1.43 Million To Study Cancer In Eastern Kentucky
9/23/2011

The University of Kentucky's Dr. Susanne Arnold and colleagues were awarded a grant by the Department of Defense to study potential environmental reasons for the high lung cancer rates in Eastern Kentucky. The grant is for $1.43 million over three years and the study began on Sept. 15...

Elderly Breast Cancer Patients Risk Treatment Discrimination
9/23/2011

Women diagnosed with breast cancer late in life are at greater risk of dying from the disease than younger patients, assuming they survive other age-related conditions, according to a study to be presented at the 2011 European Multidisciplinary Cancer Congress on Saturday. The results point to shortcomings in patient care for elderly women as well as differences in the progress of the disease...

Non-Disease Virus Kills Breast Cancer Cells In Lab
9/23/2011

A virus that infects humans without causing disease kills breast cancer cells in the laboratory. Researchers from Pennsylvania State University (Penn State) College of Medicine in the US, tested an unaltered form of adeno-associated virus type 2 (AAV2) on three different human breast cancer types representing different stages of cancer and found it targeted all of them...

Cellular Origin Of A Rare Form Of Breast Cancer Identified
9/23/2011

Identifying the cellular origins of breast cancer might lead to earlier diagnosis and more efficient management of the disease...

Mastectomy Mystery; Why It's A Choice When Cancer Isn't Evident
9/23/2011

Why would a woman with cancer in one breast make the decision to have both removed, even if there is no indication that the cancer will develop in the other breast? Researchers at Wake Forest Baptist Medical Center set out to answer that question. Their findings are published in this month's issue of The American Journal of Surgery. Lead author and researcher Marissa Howard-McNatt, M.D...

Potential Improved Test For Adulterated Heparin
9/23/2011

Scientists are reporting refinement of a new test that promises to help assure the safety of supplies of heparin, the blood thinner taken by millions of people worldwide each year to prevent blood clots. The test can quickly and economically detect adulterants, including the substance responsible for hundreds of illnesses and deaths among patients taking heparin in 2008...

Another Step Toward Resisting Breast Cancer
9/23/2011

Medical researchers at the University of Leeds have come a step closer to understanding how to stop breast cancers from coming back. Their findings, published in the International Journal of Cancer, suggest that some novel drugs that are being developed to tackle other cancers should be considered as a future treatment for breast cancer too...

New Data Suggest OncoHealth's HPV E6 And E7 Tests Can Distinguish Cervical Disease From Clinically Insignificant HPV Infection
9/22/2011

OncoHealth Corporation, a protein biomarker diagnostics company, announced new study data showing that the company's proprietary HPV E6 and E7 oncoprotein assays correlated with cervical disease grade and may distinguish cervical disease or cervical cancer from clinically insignificant HPV infection...

Patients With Fatalistic Attitudes Have Lower Cancer Screening Rates
9/22/2011

According to a study published in a recent issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, colorectal cancer screening rates among people without financial means remain to be low despite free health care being offered. Psychologists suggest the cause may be an idea called 'cancer fatalism'. Anne Miles, Ph.D...